Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer
This study is currently recruiting participants.
Verified February 2013 by University of Alabama at Birmingham
Study NCT01438307   Information provided by University of Alabama at Birmingham

First Received on September 15, 2011.   Last Updated on February 11, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Non-small Cell Lung Cancer (NSCLC)
Stage IV NSCLC
Metastatic NSCLC
Additional conditions recognized in this trial
Carcinoma, Non-Small-Cell Lung
Lung Neoplasms
More general conditions related to this trial
Bronchial Neoplasms
Carcinoma, Bronchogenic
Lung Diseases
Neoplasms
Neoplasms by Site
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Interventions listed in this trial
Cabazitaxel-XRP6258
Sponsors listed in this trial
University of Alabama at Birmingham
Sanofi


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services